Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Antiepileptic drug response in temporal lobe epilepsy A clinical and MRI morphometry study

Texto completo
Autor(es):
Bilevicius, E. [1] ; Yasuda, C. L. [1] ; Silva, M. S. [2] ; Guerreiro, C. A. M. [3] ; Lopes-Cendes, I. [2] ; Cendes, F. [3, 1]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Univ Estadual Campinas, Neuroimaging Lab, BR-13083970 Campinas, SP - Brazil
[2] Univ Estadual Campinas, Dept Genet, BR-13083970 Campinas, SP - Brazil
[3] Univ Estadual Campinas, Dept Neurol, BR-13083970 Campinas, SP - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: Neurology; v. 75, n. 19, p. 1695-1701, NOV 9 2010.
Citações Web of Science: 36
Resumo

Objective: To investigate the relationship between brain MRI and clinical characteristics and patterns of antiepileptic drug (AED) response in patients with mesial temporal lobe epilepsy (MTLE). Methods: A total of 165 MTLE patients were divided into seizure-free with AED (AED responders, n = 50), pharmacoresistant (n = 87), and remitting-relapsing seizure control group (n = 28). All groups were evaluated regarding age, frequency of seizures, and age at epilepsy onset, duration of epilepsy, febrile seizures, presence and side of hippocampal atrophy (HA), and initial precipitating injuries. For gray matter (GM) MRI voxel-based morphometry (VBM) we selected only patients with unilateral HA on visual MRI analysis (n = 100). Comparisons were made between all groups and 75 healthy controls. Results: Age at epilepsy onset was lower (p = 0.005) and initial frequency of seizures was higher in the pharmacoresistant compared with the other 2 groups (p = 0.018). All groups showed GM atrophy compared to controls in ipsilateral hippocampus, bilateral parahippocampal gyri, frontal, occipital, parietal, and cerebellar areas. In the AED responders group, such findings were more restricted to areas ipsilateral to the epileptic focus and more widespread in the pharmacoresistant and remitting-relapsing groups. VBM pairwise comparisons showed areas with GM volume reduction in the pharmacoresistant and remitting-relapsing groups compared with AED responders in bilateral periorbital frontal (p < 0.01), cingulum (p < 0.05), and temporal lobe contralateral to the epileptic focus (p < 0.05). Conclusions: Pharmacoresistant and remitting-relapsing groups presented a similar pattern of GM atrophy, which was more widespread compared with AED responders. Conversely, age at epilepsy onset was lower and initial seizure frequency was higher in pharmacoresistant patients. Neurology(R) 2010;75:1695-1701 (AU)

Processo FAPESP: 06/50626-0 - Análise de fatores relacionados a resistência ao tratamento com drogas anti-epiléticas em epilepsias parciais
Beneficiário:Elizabeth Bilevicius
Linha de fomento: Bolsas no Brasil - Doutorado Direto